| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 86.14B | 87.93B | 92.75B | 85.60B | 74.12B | 67.56B |
| Gross Profit | 18.40B | 18.74B | 19.27B | 18.84B | 15.33B | 13.31B |
| EBITDA | 5.53B | 6.97B | 7.26B | 7.04B | 5.27B | 4.08B |
| Net Income | 3.09B | 3.19B | 3.35B | 2.84B | 3.07B | 2.34B |
Balance Sheet | ||||||
| Total Assets | 75.44B | 69.98B | 69.70B | 65.95B | 55.38B | 55.95B |
| Cash, Cash Equivalents and Short-Term Investments | 24.44B | 22.65B | 20.61B | 18.13B | 12.76B | 12.65B |
| Total Debt | 3.89B | 3.54B | 2.92B | 2.75B | 1.90B | 3.46B |
| Total Liabilities | 52.36B | 48.46B | 50.33B | 46.55B | 39.10B | 40.36B |
| Stockholders Equity | 18.50B | 17.47B | 15.46B | 13.58B | 11.52B | 10.34B |
Cash Flow | ||||||
| Free Cash Flow | 5.05B | 3.68B | 3.74B | 9.63B | 3.15B | 3.21B |
| Operating Cash Flow | 7.22B | 5.80B | 5.13B | 10.61B | 4.03B | 4.31B |
| Investing Cash Flow | -3.53B | -3.55B | -619.44M | -9.56B | -2.60B | -4.42B |
| Financing Cash Flow | -1.91B | -2.02B | -5.12B | -621.14M | -1.78B | 1.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$694.14B | 11.05 | 19.76% | 5.00% | 9.21% | 4.23% | |
71 Outperform | HK$36.33B | 5.77 | 17.96% | 5.70% | -6.76% | -10.28% | |
68 Neutral | HK$221.49B | 9.19 | 15.65% | 5.20% | 2.10% | -0.45% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
49 Neutral | HK$324.66M | -22.37 | 6.01% | ― | -5.88% | ― | |
48 Neutral | HK$5.92B | 6.06 | -4.81% | ― | 4.06% | -469.59% | |
41 Neutral | HK$76.58M | -0.04 | ― | ― | ― | ― |